Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Hambley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|July 14, 2023
The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical ManagementJack Hermsen, Bryan Hambley
Therapeutic Advances in Hematology|August 6, 2016
Bortezomib for the treatment of mantle cell lymphoma: an updateBryan Hambley, Paolo F Caimi, Basem M William
American Journal of Hematology|August 11, 2019
Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns HopkinsAlexander J Ambinder, Bryan Hambley, Satish Shanbhag, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 17, 2021
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemiaKyle Zacholski, Bryan Hambley, Erin Hickey, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2021
Donor Clonal Hematopoiesis and Recipient Outcomes After TransplantationChristopher J Gibson, Haesook T Kim, Lin Zhao, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|July 14, 2023
The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical ManagementJack Hermsen, Bryan Hambley
Therapeutic Advances in Hematology|August 6, 2016
Bortezomib for the treatment of mantle cell lymphoma: an updateBryan Hambley, Paolo F Caimi, Basem M William
American Journal of Hematology|August 11, 2019
Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns HopkinsAlexander J Ambinder, Bryan Hambley, Satish Shanbhag, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 17, 2021
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemiaKyle Zacholski, Bryan Hambley, Erin Hickey, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2021
Donor Clonal Hematopoiesis and Recipient Outcomes After TransplantationChristopher J Gibson, Haesook T Kim, Lin Zhao, et al.
Pageof 1